CNMD
$35.94-0.86 (-2.34%)
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot wi...
Recent News
1 Russell 2000 Stock on Our Buy List and 2 Facing Challenges
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
CAH Posts Strong Cash Flow, Eyes Next Steps in Capital Deployment
CAH's $1.8 billion free cash flow fuels buybacks, dividends, and reinvestment, as Cardinal Health eyes disciplined capital deployment and targeted growth opportunities.
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
A Look At CONMED (CNMD) Valuation After Recent Weak Share Price Momentum
CONMED (CNMD) has been on some investors’ radars after recent share performance, with the stock showing negative returns over the past month and past 3 months. This has prompted closer attention to its current valuation. See our latest analysis for CONMED. At a share price of $38.40, CONMED’s recent 7 day share price return of 10.68% decline and year to date share price return of 5.23% decline sit alongside a 1 year total shareholder return of 34.34% decline. Together, these moves point to...
3 Stocks Under $50 with Open Questions
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.